arrow
H

Hirofumi Hamano

Tokushima University
H指数:19
被引数:1,257

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance–pharmacodynamic analysis using VigiBase

氯氮平与其他抗精神病药联合使用相关癫痫发作:一项基于VigiBase的药物警戒-药效学分析

2026-07-300
PRE
Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data

抗糖尿病药物类药物引起的肌肉萎缩相关不良事件:一项使用VigiBase数据的药物警戒分析

2026-04-140
OAAI
Global trends in systemic sclerosis-related mortality, 2001–2023: an epidemiological analysis using World Health Organization mortality data

2001–2023年系统性硬化症相关死亡率的全球趋势:一项基于世界卫生组织死亡数据的流行病学分析

2026-03-060
OAAI
Effectiveness of Statins for Oxaliplatin-Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study

他汀类药物对奥沙利铂诱导的周围神经病变的疗效:一项多中心回顾性观察性研究

2025-09-290
OAAI
Global trends in mortality related to pulmonary embolism: an epidemiological analysis of data from the World Health Organization mortality database from 2001 to 2023

全球肺栓塞相关死亡的趋势:基于2001年至2023年世界卫生组织死亡数据库的流行病学分析

2025-07-310
PRE
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database

基于真实世界数据库识别 mogamulizumab 诱导的免疫相关不良事件的不良药物警戒研究

2025-07-010
OAAI
Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab-based breast cancer therapy: Disproportionality analysis using VigiBase

将曲妥珠单抗为基础的乳腺癌治疗中加入帕妥珠单抗后不良事件谱变化的综合分析:使用VigiBase进行不成比例性分析

2025-05-080
PRE